Xiafei Hong
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Lipid metabolism and disorders 3
- Gastroenterology top 10%
-
- Pancreatic and Hepatic Oncology Research 16
- Lung Cancer Research Studies 4
-
- Neuroendocrine Tumor Research Advances 9
-
- Epigenetics and DNA Methylation 5
-
- Neuroblastoma Research and Treatments 4
-
- Pancreatitis Pathology and Treatment 3
- Cited by
- Endocrinology, Diabetes and MetabolismCardiology and Cardiovascular MedicineGastroenterology
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiafei Hong
32 papers receiving 525 citations
Peers
Comparison fields: 5 of 78
- Endocrinology, Diabetes and Metabolism 134
- Cardiology and Cardiovascular Medicine 169
- Gastroenterology 31
- Oncology 141
- Cancer Research 59
Countries citing papers authored by Xiafei Hong
This map shows the geographic impact of Xiafei Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiafei Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiafei Hong more than expected).
Fields of papers citing papers by Xiafei Hong
This network shows the impact of papers produced by Xiafei Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiafei Hong. The network helps show where Xiafei Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiafei Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 16 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 17 | |
| 8 | 2018 | 63 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 12 | |
| 11 | 2016 | 5 | |
| 12 | 2016 | 21 | |
| 13 | 2015 | 26 | |
| 14 | 2015 | 8 | |
| 15 | 2015 | 16 | |
| 16 | 2014 | 21 | |
| 17 | 2014 | 152 | |
| 18 | 2014 | 5 | |
| 19 | 2012 | 6 | |
| 20 | 2001 | 20 |
About Xiafei Hong
Xiafei Hong is a scholar working on Oncology, Gastroenterology and Neurology, having authored 33 papers that have together received 532 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Neuroendocrine Tumor Research Advances (9 papers), Epigenetics and DNA Methylation (5 papers), Neuroblastoma Research and Treatments (4 papers), Lung Cancer Research Studies (4 papers), Pancreatitis Pathology and Treatment (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Lipid metabolism and disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (134 citations), Cardiology and Cardiovascular Medicine (169 citations) and Gastroenterology (31 citations). Xiafei Hong has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yupei Zhao, Wenming Wu, Guoyue Yuan, Weiyun Qian, Wenjun Sun, Libin Zhou, Hao Hu, Shuqin Yu, Dong Wang and Ling Yang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.